BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nakada K, Matsuhashi N, Iwakiri K, Oshio A, Joh T, Higuchi K, Haruma K. Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms. World J Gastroenterol 2017; 23(28): 5216-5228 [PMID: 28811716 DOI: 10.3748/wjg.v23.i28.5216]
URL: https://www.wjgnet.com/1007-9327/full/v23/i28/5216.htm
Number Citing Articles
1
Adrian Gillissen. Gastroösophagealer Reflux als Auslöser von Husten und AsthmaPneumo News 2018; 10(7): 32 doi: 10.1007/s15033-018-1051-3
2
Kimio Isshi, Hiroto Furuhashi, Koji Nakada. Therapeutic strategy for the patients with coexisting gastroesophageal reflux disease and postprandial distress syndrome of functional dyspepsiaJGH Open 2020; 4(4): 582 doi: 10.1002/jgh3.12299
3
Cheal Wung Huh, Young Hoon Youn, Da Hyun Jung, Ra Ri Cha, Yeon Ji Kim, Kyoungwon Jung, Kyung Ho Song, Ki Bae Bang, Chung Hyun Tae, Soo In Choi, Cheol Min Shin. Efficacy of Tegoprazan in Patients With Functional Dyspepsia: A Prospective, Multicenter, Single-arm StudyJournal of Neurogastroenterology and Motility 2024; 30(3): 313 doi: 10.5056/jnm23150
4
Kimio Isshi, Nobuyuki Matsuhashi, Takashi Joh, Kazuhide Higuchi, Katsuhiko Iwakiri, Takeshi Kamiya, Noriaki Manabe, Maiko Ogawa, Seiji Arihiro, Ken Haruma, Koji Nakada. Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational studyJournal of Gastroenterology 2019; 54(6): 492 doi: 10.1007/s00535-019-01546-0
5
Pietro Crispino, Tiziana Ciarambino, Mauro Giordano. Variation in Fatty Acid Synthase, Ki67 and p53 Esophageal Mucosa Expressions in Barrett’s Esophagus Patients Treated for One Year with Two Esomeprazole Different RegimensCurrent Issues in Molecular Biology 2023; 45(6): 4701 doi: 10.3390/cimb45060299
6
Koji Nakada, Atsushi Oshio, Nobuyuki Matsuhashi, Katsuhiko Iwakiri, Takeshi Kamiya, Noriaki Manabe, Takashi Joh, Kazuhide Higuchi, Ken Haruma. Causal effect of anxiety and depression status on the symptoms of gastroesophageal reflux disease and functional dyspepsia during proton pump inhibitor therapyEsophagus 2023; 20(2): 309 doi: 10.1007/s10388-022-00960-3
7
Tatsuya Nakada, Kimio Isshi, Nobuyuki Matsuhashi, Katsuhiko Iwakiri, Takeshi Kamiya, Noriaki Manabe, Kazuhide Higuchi, Takashi Joh, Atsushi Oshio, Maiko Ogawa, Atsushi Hokari, Masayuki Saruta, Ken Haruma, Koji Nakada. Comparison of the effects of individual symptoms of gastroesophageal reflux disease co‐existing functional dyspepsia on patients' daily lives: A prospective, observational studyJGH Open 2022; 6(12): 886 doi: 10.1002/jgh3.12837
8
Maiko Ogawa, Seiji Arihiro, Nobuyuki Matsuhashi, Takashi Joh, Kazuhide Higuchi, Katsuhiko Iwakiri, Takeshi Kamiya, Noriaki Manabe, Kimio Isshi, Tatsuya Nakada, Atsushi Hokari, Masayuki Saruta, Atsushi Oshio, Ken Haruma, Koji Nakada. The early therapeutic response at 2 weeks is a crucial predictor of proton pump inhibitor-refractory gastroesophageal reflux diseaseEsophagus 2021; 18(2): 398 doi: 10.1007/s10388-020-00792-z
9
Noriaki Manabe, Takashi Joh, Kazuhide Higuchi, Katsuhiko Iwakiri, Takeshi Kamiya, Ken Haruma, Koji Nakada. Clinical significance of gastroesophageal reflux disease with minimal change: a multicenter prospective observational studyScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-19408-w
10
E. V. Gorban, N. V. Korochanskaya, V. V. Gorban. CLINICAL AND FUNCTIONAL FEATURES OF GASTROESOPHAGEAL REIFLUX DISEASE, COMORBID WITH PEPTIC ULCER DISEASESouth Russian Journal of Therapeutic Practice 2020; 1(1): 78 doi: 10.21886/2712-8156-2020-1-1-78-83
11
A. Gillissen. Gastroösophagealer Reflux als Auslöser von Husten und AsthmaDer Pneumologe 2018; 15(2): 81 doi: 10.1007/s10405-017-0154-6
12
Kimio Isshi, Hiroto Furuhashi, Akio Koizumi, Koji Nakada. Effects of coexisting upper gastrointestinal symptoms on daily life and quality of life in patients with gastroesophageal reflux disease symptomsEsophagus 2021; 18(3): 684 doi: 10.1007/s10388-020-00801-1
13
Yuta Yokoya, Ataru Igarashi, Akihito Uda, Hisato Deguchi, Toshihisa Takeuchi, Kazuhide Higuchi. Cost-utility analysis of a ‘vonoprazan-first’ strategy versus ‘esomeprazole- or rabeprazole-first’ strategy in GERDJournal of Gastroenterology 2019; 54(12): 1083 doi: 10.1007/s00535-019-01609-2
14
Kimio Isshi, Nobuyuki Matsuhashi, Takashi Joh, Kazuhide Higuchi, Katsuhiko Iwakiri, Takeshi Kamiya, Noriaki Manabe, Tatsuya Nakada, Maiko Ogawa, Seiji Arihiro, Ken Haruma, Koji Nakada. Clinical features and therapeutic responses to proton pump inhibitor in patients with severe reflux esophagitis: A multicenter prospective observational studyJGH Open 2021; 5(1): 99 doi: 10.1002/jgh3.12455
15
Hye-kyung Jung, Myung-Gyu Choi, Myung-Ki Baek, Justin C Y Wu. Development and Psychometric Assessment of a Self-evaluation Questionnaire for Gastroesophageal Reflux DiseaseJournal of Neurogastroenterology and Motility 2018; 24(4): 584 doi: 10.5056/jnm18085